Nanobody-targeted photodynamic therapy (NB-PDT) has been developed as a potent and more tumor-specific approach compared to conventional PDT [1]. Interestingly, conventional PDT is able to induce immunogenic cell death, characterized by the exposure/release of damage associated molecular patterns (DAMPs) from dying cells, which can result in an anti-tumor immune response. In this study, we aim at understanding the first steps towards immune-modulation triggered by NB-PDT. For this, the EGFR-targeted NB 7D12 was conjugated to the photosensitizer IRDye700DX and used to perform NB-PDT on EGFR-overexpressing A431 tumor cells, exposed to 30 minute incubation with the conjugates and followed by a light dose of 10 J/cm2. The cytoplasmic DAMP HSP70 was detected on the cell membrane after mild NB-PDT (1 nM conjugate), while it was detected in the medium after highly toxic NB-PDT (25 nM conjugate). The nuclear DAMP HMGB1 was found in the cell cytoplasm under both NB-PDT conditions. Furthermore, cells treated with highly toxic NB-PDT showed an increased release of the pro-inflammatory cytokines IL-1β and IL-6, and a decreased release of pro-tumoral IL-8. Lastly, medium collected from tumor cells treated with highly toxic NB-PDT was able to induce the phenotypic maturation of a dendritic cell line, as indicated by the upregulation of CD40, CD86 and MHCII. Altogether, these results are the first to indicate immune-modulation by NB-PDT, which can be exploited to increase NB-PDT efficacy even further.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.